Published April 15, 2016
| Version v1
Journal article
Open
CD4 Receptor is a Key Determinant of Divergent HIV-1 Sensing by Plasmacytoid Dendritic Cells
Creators
- 1. Icahn School of Medicine at Mount Sinai
- 2. Washington University in St. Louis
- 3. University of Chicago
Description
Plasmacytoid dendritic cells (pDC) are innate immune cells that sense viral nucleic acids through endosomal Toll-like receptor (TLR) 7/9 to produce type I interferon (IFN) and to differentiate into potent antigen presenting cells (APC). Engagement of TLR7/9 in early endosomes appears to trigger the IRF7 pathway for IFN production whereas engagement in lysosomes seems to trigger the NF-κB pathway for maturation into APC. We showed previously that HIV-1 (HIV) localizes predominantly to early endosomes, not lysosomes, and mainly stimulate IRF7 rather than NF-κB signaling pathways in pDC. This divergent signaling may contribute to disease progression through production of pro-apoptotic and pro-inflammatory IFN and inadequate maturation of pDCs. We now demonstrate that HIV virions may be re-directed to lysosomes for NF-κB signaling by either pseudotyping HIV with influenza hemagglutinin envelope or modification of CD4 mediated-intracellular trafficking. These data suggest that HIV envelope-CD4 receptor interactions drive pDC activation toward an immature IFN producing phenotype rather than differentiation into a mature dendritic cell phenotype.
Data availability
All relevant data are within the paper and its Supporting Information files.Files
journal.ppat.1005553.pdf
Files
(17.5 MB)
| Name | Size | Download all |
|---|---|---|
|
Article md5:caa7918dfcc7a4efd00088b4803ea65f |
13.3 MB | Preview Download |
|
Supporting information md5:517af5f9e9d2870d68cc3a2659d13659 |
4.1 MB | Preview Download |
Additional details
Identifiers
- DOI
- 10.1371/journal.ppat.1005553
- Other
- oai:uchicago.tind.io:7206
Funding
- National Institutes of Health
- K08 AI093153
- National Institutes of Health
- R37 AI044628
- National Institutes of Health
- R01AI081848
- National Institutes of Health
- U01 A1067854